Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage forms

Abstract

Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage formsTwo spectrophotometric methods for the determination of ceftazidime (CFZM) in either pure form or in its pharmaceutical formulations are described. The first method is based on the reaction of 3-methylbenzothiazolin-2-one hydrazone (MBTH) with ceftazidime in the presence of ferric chloride in acidic medium. The resulting blue complex absorbs at λmax628 nm. The second method describes the reaction between the diazotized drug andN-(1-naphthyl)ethylenediamine dihydrochloride (NEDA) to yield a purple colored product with λmaxat 567 nm. The reaction conditions were optimized to obtain maximum color intensity. The absorbance was found to increase linearly with increasing the concentration of CFZM; the systems obeyed the Beer's law in the range 2-10 and 10-50 μg mL-1for MBTH and NEDA methods, resp.LOD, LOQand correlation coefficient values were 0.15, 0.79 and 0.50, 2.61. No interference was observed from common excipients present in pharmaceutical formulations. The proposed methods are simple, sensitive, accurate and suitable for quality control applications.